Aker BioMarine ASA (OSL:AKBM)

Revenue by Product

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Consumer Health Products	1.13B
Human Health Ingredients	906.61M
Human Health Ingredients Growth	-59.20%
Emerging Businesses	104.32M

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Americas	1.51B
Americas Growth	-11.79%
Asia Pacific	400.07M
Asia Pacific Growth	-62.93%
EMEA	171.00M
EMEA Growth	-56.63%
Norway	54.85M
Norway Growth	-84.56%